Age and Sex Shape Cancer Immunity, New Research Reveals

A groundbreaking study published in Nature Aging reveals how biological sex and aging significantly influence cancer immunity and immunotherapy effectiveness. Researchers from Mass General Brigham Cancer Institute combined mouse experiments with human data to show that middle-aged individuals experience a decline in naive CD8 T cells, critical immune cells that recognize cancer antigens. The research specifically identified how lymph node contraction during aging compromises the immune system's ability to fight cancer. These findings have important implications for developing more personalized cancer immunotherapy treatments based on age and sex, potentially improving treatment outcomes for patients across different demographics.